摘要
2,3-二氢-1-茚酮与手性辅基(R)-苯乙胺缩合得到(R)-(+)-N-(1-苯基乙基)-2,3-二氢茚-1-亚胺,经硼氢化钠不对称还原、氢解脱苄制得(R)-1-氨基茚满盐酸盐,再与3-溴丙炔缩合、成甲磺酸盐制得抗帕金森病药甲磺酸雷沙吉兰,总收率为9.5%。
Rasagiline mesylate, an antiparkinson drug, was synthesized from indanone by condensation with (R)-phenylethylamine to give (R)- (+)-N-(1-phenylethyl)indan-l-ylidene amine, which was subjected to asymmetrical reduction and catalytic hydrogenolysis to give (R)-1-indanamine hydrochloride, followed by condensation with propargyl bromide and salt formation with an overall yield of 9.5 %.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2011年第1期4-6,共3页
Chinese Journal of Pharmaceuticals